Furthermore, DYRK1A phosphorylates several neurodegenerative diseases associated proteins, such as APP and α-synuclein, and has been associated with intellectual disability and targeted to improve cognitive performance in subjects with DS (without AD) and other intellectual disabilities. Here, APP is linked to Alzheimer disease.